Zili Gu

812 total citations
18 papers, 617 citations indexed

About

Zili Gu is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Zili Gu has authored 18 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomedical Engineering, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Zili Gu's work include Nanoplatforms for cancer theranostics (11 papers), Immunotherapy and Immune Responses (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Zili Gu is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Immunotherapy and Immune Responses (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Zili Gu collaborates with scholars based in Netherlands, China and United States. Zili Gu's co-authors include Luis J. Cruz, Ferry Ossendorp, Guimei Lin, Yanbin Shi, Hao Yang, Candido G. Da Silva, Koen van der Maaden, Qingjie Wang, Timo Schomann and Peter ten Dijke and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Acta Biomaterialia.

In The Last Decade

Zili Gu

18 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zili Gu Netherlands 13 317 252 235 186 99 18 617
Dongyang Zhao China 15 208 0.7× 277 1.1× 179 0.8× 130 0.7× 79 0.8× 17 610
Xiqin Yang China 15 335 1.1× 283 1.1× 238 1.0× 142 0.8× 81 0.8× 16 644
Jiangkang Xu China 11 320 1.0× 245 1.0× 198 0.8× 99 0.5× 57 0.6× 12 623
Tianqun Lang China 17 568 1.8× 393 1.6× 363 1.5× 217 1.2× 179 1.8× 30 938
Dongjuan Yang China 10 410 1.3× 390 1.5× 388 1.7× 151 0.8× 114 1.2× 25 909
Yunai Du China 9 549 1.7× 232 0.9× 203 0.9× 217 1.2× 120 1.2× 11 778
Zhenwei Su China 11 321 1.0× 214 0.8× 185 0.8× 161 0.9× 142 1.4× 12 589
Xinying Yu China 12 330 1.0× 157 0.6× 148 0.6× 125 0.7× 51 0.5× 18 572
Yue Yan China 16 535 1.7× 384 1.5× 258 1.1× 184 1.0× 85 0.9× 39 876

Countries citing papers authored by Zili Gu

Since Specialization
Citations

This map shows the geographic impact of Zili Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zili Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zili Gu more than expected).

Fields of papers citing papers by Zili Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zili Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zili Gu. The network helps show where Zili Gu may publish in the future.

Co-authorship network of co-authors of Zili Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Zili Gu. A scholar is included among the top collaborators of Zili Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zili Gu. Zili Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gu, Zili, Jie Yin, Candido G. Da Silva, et al.. (2024). Therapeutic liposomal combination to enhance chemotherapy response and immune activation of tumor microenvironment. Journal of Controlled Release. 373. 38–54. 5 indexed citations
2.
Yang, Hao, Zili Gu, Maria Chiara Gelmi, et al.. (2024). Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma Model. Investigative Ophthalmology & Visual Science. 65(1). 42–42. 4 indexed citations
3.
Yang, Hao, et al.. (2023). Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy. SHILAP Revista de lepidopterología. 4(4). e339–e339. 40 indexed citations
4.
Gu, Zili, Candido G. Da Silva, Qi Liu, et al.. (2023). Dual‐Targeting Nanoliposome Improves Proinflammatory Immunomodulation of the Tumor Microenvironment. Advanced Healthcare Materials. 12(31). e2302046–e2302046. 6 indexed citations
5.
Gu, Zili, Hao Yang, Timo Schomann, et al.. (2023). Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation. Journal of Controlled Release. 357. 531–544. 64 indexed citations
6.
7.
Yang, Hao, Chih Kit Chung, Zili Gu, et al.. (2022). Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment. Molecular Biomedicine. 3(1). 26–26. 34 indexed citations
8.
He, Yuanyuan, Raimundo Fernandes de Araújo Júnior, Timo Schomann, et al.. (2022). Effective breast cancer therapy based on palmitic acid-loaded PLGA nanoparticles. Biomaterials Advances. 145. 213270–213270. 16 indexed citations
9.
Gu, Zili, Candido G. Da Silva, Hao Yang, et al.. (2022). Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer. Journal of Controlled Release. 353. 490–506. 29 indexed citations
10.
Dong, Xiaoxv, Yawen Zeng, Zhiqin Zhang, et al.. (2021). Hypericin-mediated photodynamic therapy for the treatment of cancer: a review. Journal of Pharmacy and Pharmacology. 73(4). 425–436. 65 indexed citations
11.
Gu, Zili, Candido G. Da Silva, Koen van der Maaden, Ferry Ossendorp, & Luis J. Cruz. (2020). Liposome-Based Drug Delivery Systems in Cancer Immunotherapy. Pharmaceutics. 12(11). 1054–1054. 116 indexed citations
12.
Lin, Guimei, et al.. (2020). Performance of heterotopic bone elicited with bone morphogenic protein-2 microspheres as a bone repair material. Materials & Design. 191. 108657–108657. 10 indexed citations
13.
Huang, Yi, Yanbin Shi, Qingjie Wang, et al.. (2019). Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma. Journal of Controlled Release. 316. 208–222. 33 indexed citations
14.
Huang, Yi, Zili Gu, Qifeng Yang, et al.. (2019). Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future. Purinergic Signalling. 15(1). 53–67. 22 indexed citations
15.
Gu, Zili, Abdul Sami Shaikh, & Guimei Lin. (2018). Novel 'Stereoscopic Response' Strategy Can Be Used in Combination Therapy. Critical Reviews in Therapeutic Drug Carrier Systems. 35(4). 369–390. 2 indexed citations
16.
Gu, Zili, Qingjie Wang, Yanbin Shi, et al.. (2018). Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity. Journal of Controlled Release. 286. 369–380. 78 indexed citations
17.
Gu, Zili, et al.. (2017). NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel. Colloids and Surfaces B Biointerfaces. 160. 395–405. 20 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongyang Zhao Breakdown of academic impact, for papers by Xiqin Yang Breakdown of academic impact, for papers by Jiangkang Xu Breakdown of academic impact, for papers by Tianqun Lang Breakdown of academic impact, for papers by Dongjuan Yang Breakdown of academic impact, for papers by Yunai Du Breakdown of academic impact, for papers by Zhenwei Su Breakdown of academic impact, for papers by Xinying Yu Breakdown of academic impact, for papers by Yue Yan
Rankless by CCL
2026